Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 314

1.

Utility of hemoglobin A1c in predicting diabetes risk.

Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ.

J Gen Intern Med. 2004 Dec;19(12):1175-80.

2.

The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers.

Inoue K, Matsumoto M, Kobayashi Y.

Diabetes Res Clin Pract. 2007 Sep;77(3):451-8. Epub 2007 Mar 7.

PMID:
17346846
3.

Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.

Ko GT, Chan JC, Tsang LW, Cockram CS.

Diabetes Care. 2000 Dec;23(12):1770-3.

4.

Screening for diabetes in an outpatient clinic population.

Edelman D, Edwards LJ, Olsen MK, Dudley TK, Harris AC, Blackwell DK, Oddone EZ.

J Gen Intern Med. 2002 Jan;17(1):23-8.

5.

A two-step screening, measurement of HbA1c in association with FPG, may be useful in predicting diabetes.

Nomura K, Inoue K, Akimoto K.

PLoS One. 2012;7(4):e36309. doi: 10.1371/journal.pone.0036309. Epub 2012 Apr 27.

6.

Do non-glycaemic markers add value to plasma glucose and hemoglobin a1c in predicting diabetes? Yuport health checkup center study.

Kashima S, Inoue K, Matsumoto M, Akimoto K.

PLoS One. 2013 Jun 20;8(6):e66899. doi: 10.1371/journal.pone.0066899. Print 2013.

7.

A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.

Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, Weinehall L.

J Intern Med. 2006 Sep;260(3):263-71. Erratum in: J Intern Med. 2006 Nov;260(5):491.

8.

Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.

Lin CC, Chen CC, Chen FN, Li CI, Liu CS, Lin WY, Yang SY, Lee CC, Li TC.

Am J Med. 2013 Nov;126(11):1017.e1-10. doi: 10.1016/j.amjmed.2013.04.015. Epub 2013 Aug 29.

PMID:
23993260
9.

Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E; DESIR Study Group.

Diabetes Care. 2006 Jul;29(7):1619-25.

PMID:
16801588
10.

Hemoglobin A1c in predicting progression to diabetes.

Nakagami T, Tajima N, Oizumi T, Karasawa S, Wada K, Kameda W, Susa S, Kato T, Daimon M.

Diabetes Res Clin Pract. 2010 Jan;87(1):126-31. doi: 10.1016/j.diabres.2009.11.001. Epub 2009 Nov 28.

PMID:
19945760
11.

Use of haemoglobin A1c to detect impaired fasting glucose or Type 2 diabetes in a United Kingdom community based population.

Kumaravel B, Bachmann MO, Murray N, Dhatariya K, Fenech M, John WG, Scarpello TJ, Sampson MJ; University of East Anglia Impaired Fasting Glucose (UEA-IFG) Study Group.

Diabetes Res Clin Pract. 2012 May;96(2):211-6. doi: 10.1016/j.diabres.2011.12.004. Epub 2012 Jan 17.

PMID:
22257419
12.

Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening.

Ginde AA, Cagliero E, Nathan DM, Camargo CA Jr.

Acad Emerg Med. 2008 Dec;15(12):1241-7. doi: 10.1111/j.1553-2712.2008.00240.x. Epub 2008 Sep 8.

13.

Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population.

Ginde AA, Cagliero E, Nathan DM, Camargo CA Jr.

J Gen Intern Med. 2008 Sep;23(9):1346-53. doi: 10.1007/s11606-008-0661-6. Epub 2008 Jun 10.

14.

Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.

Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.

Diabetes Care. 1998 Aug;21(8):1221-5.

PMID:
9702423
15.

HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD; Early Diabetes Intervention Program (EDIP).

Diabetes Care. 2001 Mar;24(3):465-71.

PMID:
11289469
16.

Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.

Inoue K, Matsumoto M, Akimoto K.

Diabet Med. 2008 Oct;25(10):1157-63. doi: 10.1111/j.1464-5491.2008.02572.x.

PMID:
19046193
18.

Fasting plasma glucose and 5-year incidence of diabetes in the JPHC diabetes study - suggestion for the threshold for impaired fasting glucose among Japanese.

Noda M, Kato M, Takahashi Y, Matsushita Y, Mizoue T, Inoue M, Tsugane S, Kadowaki T.

Endocr J. 2010;57(7):629-37. Epub 2010 May 28.

19.

A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.

Cosson E, Hamo-Tchatchouang E, Banu I, Nguyen MT, Chiheb S, Ba H, Valensi P.

Diabetes Metab. 2010 Sep;36(4):312-8. doi: 10.1016/j.diabet.2010.02.004.

Items per page

Supplemental Content

Write to the Help Desk